Oslo Norway, March 23, 2023
Today LINK Medical has announced the integration of Pharm Assist into the LINK Medical family. Pharm Assist is a consultant and service company based in Uppsala Sweden offering regulatory solutions for Medicinal and MedTech products since 1996. The Pharm Assist team is a highly qualified group of specialists with a strong scientific and regulatory background. They will continue to provide tailor-made services in Regulatory Affairs, Pharmacovigilance, Medical Writing, and Good Distribution Practice (GDP) to national and international companies as part of the wider LINK Medical group.
Pharm Assist was acquired in May 2022 by the Life Science Service Group (“LSSG”), established by Serendipity Partners, who also own LINK Medical. As the integration is now being finalized, customers will benefit from an extended pool of knowledgeable experts as well as a wider range of services, from early-phase development to post-marketing.
“We are very excited to have Pharm Assist integrate with our network of expert teams, especially strengthening our already robust regulatory group making us very unique in our industry. Our Regulatory team across the Nordics now has over 60 specialists, including more than 15 in Sweden. The integration enables LINK Medical to provide strong and comprehensive support for Biotech, MedTech, and Pharma companies in need of a strategic partner. Companies have the flexibility of working with us from concept to market, for stand-alone support on marketed products or outsourced when needed.” Said Sissel Lønning Andresen, CEO at LINK Medical
“LSSG is a great home for Pharm Assist as we share the same company values and strategic vision as Serendipity and LINK Medical. Our clients will get personal links to our consultants through both a larger geographic footprint and service offering in the Nordics and northern Europe.” Said Dr. Ehrnebo, founder and owner of Pharm Assist
About LINK Medical
LINK Medical is a full-service contract research organization (CRO) providing product development services for the pharmaceutical and medical device industries across Northern Europe. We offer a well-integrated local presence in the Nordics UK and Germany. Reaching from early phase development to post-marketing, our internal network of specialists provides expert guidance across every aspect of a project – all from ONE source. Our promise is to improve and accelerate your product development through transformative methods, active communication, and optimal solutions. As a strategic partner, we provide expert competence and technology to enable evidence-based decision-making that supports the delivery of superior clinical outcomes.
For further information on LINK Medical Research visit www.LINKMedical.eu
For more information, please contact LINK Medical
Sissel Lønning Andresen, CEO
Tel: +47 41641451
Editorial contact:
Claudia Wennberg, Sr. Marketing and Brand Manager
+46 708244398
Local contacts for the strengthened teams from the integration
Regulatory, GDP, & Safety
Kristine Nygren,
Regulatory Director, Sweden
Email
Connect via LinkedIn
Kristine Nygren, Director Regulatory, Sweden
Prior to joining LINK in January 2021, Kristine’s expertise included 20 years of experience within Regulatory Affairs. She has worked with Pharmaceuticals, Medical Device, and In-vitro diagnostics – with both Global- and European focus. Kristine has also over 10 years of leadership experience from various management positions in the Pharmaceutical Industry and at the Department of Product information at the Medical Product Agency in Sweden.
Sari Öbrink,
Group Manager GDP & Safety
Email
Connect via LinkedIn
Sari Öbrink,
Sari Öbrink is a pharmacist and she has worked in Pharmacovigilance, Quality Assurance (QA), and Good Distribution Practice (GDP) since 2016. She has 30 years of experience in different areas within the pharmaceutical industry including 2 years with competent authorities. She has supported pharmaceutical companies with the maintenance of pharmacovigilance (PV) systems and quality management systems. She acts as a Qualified Person for Pharmacovigilance (QPPV), deputy QPPV, and local responsible person for PV in the Nordic countries, and supports CROs as a safety officer in clinical trials. She has also taken roles as a Responsible Person for wholesale. She has performed several PV and GDP audits.
Elisabeth Widmark,
Group Manager Regulatory
Email
Connect via LinkedIn
Elisabeth holds an M.Sc. in Pharmacy and joined Pharm Assist in 2018. She has over 15 years of experience in international and local Regulatory Affairs. Her expertise lies foremost with Regulatory CMC and Global Regulatory Affairs, but she has also extensive experience with Regulatory Affairs post-marketing. She has several years of experience within Good Distribution Practice acting as a Responsible Person for Wholesale for both small national and large global companies. Elisabeth has several years of leadership experience in management positions in the Pharmaceutical Industry.
Medical Device – Sweden
Erwin de Buijzer,
Email
Connect via LinkedIn
Erwin de Buijzer, Medical Device, Director
After working a few years working as a medical doctor in surgery and intensive care, Erwin focused on combining his interest in innovation and digitalization with his medical background. Subsequently, he broadened his horizon with an executive MBA at a globally recognized school. This step enabled him to develop his career in commercial organizations in pharma and medical devices. Thereafter, he brought a highly innovative liver diagnostic startup – combining a medical device and a diagnostic drug – from academic concept to a commercially viable product. Erwin has also worked as a consultant in digital health and as a coach for startups before joining LINK Medical as head of the Medical Devices department at the start of 2021.
Medical Writing
Magnus Ringbom,
Medical Writing, Director
Email
Connect via LinkedIn
With over 20 years in Clinical Operations, Magnus has a broad experience in clinical trials. During these years, he has worked within the CRO business in various positions (CRA, Project Manager, Clinical Research Manager including Manager for a Nordic Start-Up group). He has worked part-time in Medical Writing since 2010. Additionally, he has been an assistant course leader for the Clinical Drug Development course at Uppsala University. Magnus has a broad experience in terms of operations and protocol development (various indications, Phase I-IV including registry-based clinical trials and pharmacovigilance, both investigational medicinal products and medical devices). Additionally, he has been involved in many advisory functions (e.g. study design, Scientific Advice-meetings). Magnus joined LINK Medical in 2021 as Head of the Medical Writing team. He and his team are dedicated to Medical Writing aiming for a customer focused high-quality delivery in each task.
